Detalhe da pesquisa
1.
Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?
Crohns Colitis 360
; 5(4): otad040, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-38028954
2.
Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients.
J Crohns Colitis
; 16(9): 1347-1353, 2022 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358307
3.
Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study.
Inflamm Bowel Dis
; 28(10): 1506-1512, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34849919